Old Web
English
Sign In
Acemap
>
authorDetail
>
Mona Marabani
Mona Marabani
Canterbury Hospital
Medicine
Intensive care medicine
Biosimilar
Interchangeability
Randomized controlled trial
4
Papers
53
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A comparison of Janus kinase inhibitor safety in rheumatoid arthritis
2021
International Journal of Rheumatic Diseases
Peter Nash
Irwin Lim
Mona Marabani
Show All
Source
Cite
Save
Citations (0)
The Challenges of Switching Therapies in an Evolving Multiple Biosimilars Landscape: A Narrative Review of Current Evidence.
2020
Advances in Therapy
Brian G. Feagan
Mona Marabani
Jashin J. Wu
Freddy Faccin
Claire Spronk
Gilberto Castañeda-Hernández
Show All
Source
Cite
Save
Citations (8)
A Practical Approach to the Use of Conventional Synthetic, Biologic and Targeted Synthetic Disease Modifying Anti-Rheumatic Drugs for the Treatment of Inflammatory Arthritis in Patients with a History of Malignancy.
2018
Current Rheumatology Reports
Peter K. K. Wong
Hanish Bagga
Claire Barrett
Geoffrey Chong
Patrick Hanrahan
Teja Kodali
Mona Marabani
H. Miles Prince
John Riordan
Phillip Swarbrick
Ray White
Laurel Young
Show All
Source
Cite
Save
Citations (2)
Biosimilarity and Interchangeability: Principles and Evidence: A Systematic Review
2018
BioDrugs
Ross A. McKinnon
Matthew C. Cook
Winston Liauw
Mona Marabani
Ian C. Marschner
Nicolle H. Packer
Johannes B. Prins
Show All
Source
Cite
Save
Citations (43)
1